DE
46
8
FLS
48
-5
CHK
5
-17
KIM
51
-2
SRCL
64
17
HUM
46
-3
WFC
49
-11
WMT
62
-2
JCI
44
-3
HON
52
4
CHRW
44
-4
ICE
66
-4
SYF
57
-7
GOOGL
39
-8
NRG
44
-8
BAX
38
2
KMB
48
-3
FITB
50
-5
AES
37
-3
BA
33
-2
DE
46
8
FLS
48
-5
CHK
5
-17
KIM
51
-2
SRCL
64
17
HUM
46
-3
WFC
49
-11
WMT
62
-2
JCI
44
-3
HON
52
4
CHRW
44
-4
ICE
66
-4
SYF
57
-7
GOOGL
39
-8
NRG
44
-8
BAX
38
2
KMB
48
-3
FITB
50
-5
AES
37
-3
BA
33
-2
Financhill
Back

Immunovant Stock Predictions

Fed rate cuts could send the stock market down

Here's my #1 free indicator to use now.
Buy
64

IMVT
Immunovant

Last Price:
34.06
Seasonality Move:
51.14%

7 Day Trial

ALL ACCESS PASS

$ 7

1-day winners in this choppy market

Get the 1-day winners strategy here.

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 108.7% based on the past 5 years of stock performance.
  • Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $34.00. The Score for IMVT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • IMVT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 108.7% based on the past 5 years of stock performance.

Immunovant Stock Rating

Buy
64
Immunovant (IMVT) is a Buy

Is Immunovant overpriced?

  • Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMVT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
45.58
52-Week Low:
19.50

Prediction Charts

Market Cap:
4.98B
Price in USD:
34.00
Volume:
1.44M
Beta:
0.72

Technical Analysis

SMA50:
29.49
SMA100:
28.75
SMA200:
32.72
52-Wk Change:
47.7%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 34.00 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-19 29.64 31.17 31.44 29.63
Aug-20 31.18 31.52 31.60 30.60
Aug-21 31.58 32.46 32.64 31.26
Aug-22 32.58 31.40 32.69 31.33
Aug-23 31.67 32.42 32.54 31.30
Aug-26 32.40 32.02 32.77 31.78
Aug-27 32.01 31.72 32.13 31.15
Aug-28 31.80 31.35 31.83 31.07
Aug-29 31.70 30.98 31.99 30.96
Aug-30 31.16 30.90 31.51 30.78
Sep-3 30.98 30.44 31.67 30.01
Sep-4 30.15 30.69 30.73 29.79
Sep-5 31.10 33.62 33.69 31.05
Sep-6 34.14 34.00 34.47 32.95

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.65 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.